Novo Nordisk CEO says experimental weight loss pill could become a best-in-class drug
[ad_1] Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company’s experimental weight loss pill, amycretin, could eventually become
Read More
Pharmaceuticals
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
[ad_1] Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in
Read More
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
[ad_1] Cr | Istock | Getty Images Biotech company Viking Therapeutics has emerged as a strong potential entrant — or
Read More
CVS and Walgreens to start selling abortion pill mifepristone this month
[ad_1] A container holding boxes of Mifepristone, the first medication in a medical abortion, are prepared for patients at Alamo
Read More
New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
[ad_1] The approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from
Read More
What Eli Lilly investors can learn from the slow launch of a competitor's drug
[ad_1] Club holding Eli Lilly is expecting to get approval for its Alzheimer’s treatment in the coming weeks, but investors
Read More
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
[ad_1] Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21,
Read More
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11,
Read More
Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue
[ad_1] Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020.
Read More
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
[ad_1] Boxes of Novo Nordisk’s weight-loss drug Wegovy in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Danish drugmaker
Read More